When you need
to be sure

In the first half of 2026, we achieved strong organic growth, further margin expansion and record cash generation.

Géraldine reflects on the excellent half year results and the key achievements in H1.

We have set ambitious targets for 2027, based on our unique ability to respond to the megatrends driving growth in the TIC industry.

Using advanced mass spectrometry to ensure safer pharmaceutical packaging and medical devices.

Tailored solutions help organizations meet evolving regulatory obligations and uphold critical brand integrity.